1. Home
  2. BSRR vs FHTX Comparison

BSRR vs FHTX Comparison

Compare BSRR & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$36.25

Market Cap

418.8M

Sector

Finance

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$5.74

Market Cap

360.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
FHTX
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.8M
360.8M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
BSRR
FHTX
Price
$36.25
$5.74
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$38.50
$11.71
AVG Volume (30 Days)
71.1K
116.0K
Earning Date
05-05-2026
04-14-2026
Dividend Yield
2.89%
N/A
EPS Growth
10.28
32.48
EPS
3.11
N/A
Revenue
N/A
$22,602,000.00
Revenue This Year
$11.74
$40.91
Revenue Next Year
$3.63
$11.87
P/E Ratio
$16.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.42
$2.94
52 Week High
$38.60
$6.95

Technical Indicators

Market Signals
Indicator
BSRR
FHTX
Relative Strength Index (RSI) 49.87 52.84
Support Level $36.00 $4.44
Resistance Level $36.79 $5.83
Average True Range (ATR) 1.42 0.34
MACD -0.22 0.01
Stochastic Oscillator 54.37 74.71

Price Performance

Historical Comparison
BSRR
FHTX

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: